Schwarz Lab well-represented as presenters at RRS 2019
The Cancer Biology Division had an impressive number of presenters and attendees.
John Floberg, MD, PhD and Julie Schwarz, MD PhD Published in the Journal of Nuclear Medicine (Links to an external site)
“Altering cellular reducing potential changes 64Cu-ATSM signal with or without hypoxia.”
Schwarz receives 2019 AACR Investigator Grant
Cancer Biology Division Director & Associate Professor Dr. Julie Schwarz accepted a 2019 AACR Investigator Grant award to continue her work “Targeting CXCR2 to Improve Radiation Induced Anti-Tumor Immunity”
Collaboration with the DeNardo Lab makes WUSM News
Immune-boosting compound makes immunotherapy effective against pancreatic cancer Panni RZ, Herndon JM, Zuo C, Hegde S, Hogg GD, Knolhoff BL, Breden MA, Li X, Krisnawan VE, Khan SQ, Schwarz JK, Rogers BE, Fields RC, Hawkins WG, Gupta V, DeNardo DG. Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies. Science Translational Medicine. […]
Cutting off cervical cancer’s fuel supply stymies tumors–paper published in Cancer Research (Links to an external site)
http://medicine.wustl.edu/news/cutting-off-cervical-cancers-fuel-supply-stymies-tumors/ »